Boca Raton, FL, Dec. 01, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (INMB), a clinical-stage biotechnology company developing inflammation and immunology therapies targeting innate immune dysfunction, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results